Study Name: An Open-label Study of Vedolizumab (MLN0002) in Patients With Ulcerative Colitis and Crohn's Disease
31 locations found
- Study Name Unavailable
Location: Hamden, Connecticut 06518
- Study Name Unavailable
Location: Cheektowaga, New York 10029
- Study Name Unavailable
Location: New York, New York 10029
- Study Name Unavailable
Location: Chevy Chase, Maryland 20815
- Study Name Unavailable
Location: Charlottesville, Virginia 22908
- Study Name Unavailable
Location: Richmond, Virginia 23249
- Study Name Unavailable
Location: Charlotte, North Carolina 28207
- Study Name Unavailable
Location: Elkin, North Carolina 28621
- Study Name Unavailable
Location: Birmingham, Alabama 35233
- Study Name Unavailable
Location: San Diego, California 92114
- Study Name Unavailable
Location: San Francisco, California 94115
- Study Name Unavailable
Location: Lafayette, Colorado 80026
- Study Name Unavailable
Location: Littleton, Colorado 80120
- Study Name Unavailable
Location: Thorton, Colorado 80229
- Study Name Unavailable
Location: Jacksonville, Florida 32256
- Study Name Unavailable
Location: Miami, Florida 33172
- Study Name Unavailable
Location: Winter Park, Florida 32789
- Study Name Unavailable
Location: Atlanta, Georgia 30024
- Study Name Unavailable
Location: Decatur, Georgia 30033
- Study Name Unavailable
Location: Macon, Georgia 31201
- Study Name Unavailable
Location: Topeka, Kansas 66606
- Study Name Unavailable
Location: Louisville, Kentucky 40202
- Study Name Unavailable
Location: Baton Rouge, Louisiana 70809
- Study Name Unavailable
Location: Ann Arbor, Michigan 48109
- Study Name Unavailable
Location: Troy, Michigan 48098
- Study Name Unavailable
Location: Rochester, Minnesota 55904
- Study Name Unavailable
Location: Portland, Oregon 97225
- Study Name Unavailable
Location: Germantown, Tennessee 38138
- Study Name Unavailable
Location: San Antonio, Texas 78229
- Study Name Unavailable
Location: Tyler, Texas 75701
- Study Name Unavailable
Location: Milwaukee, Wisconsin 53226
|